However, recent studies have shown that IL-23 is also involved in tumor growth and metastasis by directly binding to the IL-23 receptor, which is expressed in a variety of in inflammation-related malignant tumors, including breast cancer [141]. This evidence concerns the gene IL23A and neoplasm.